{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:24:38Z","timestamp":1768634678399,"version":"3.49.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.clindermatol.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T17:47:43Z","timestamp":1504892863000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gynecologic and andrologic dermatology and the metabolic syndrome"],"prefix":"10.1016","volume":"36","author":[{"given":"Maria Magdalena","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Leader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kroumpouzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2017.09.013_bb0005","series-title":"Endotext","article-title":"Metabolic syndrome","author":"Lam","year":"2000"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archdermatol.2012.1381","article-title":"Dyslipidemia in granuloma annulare: A case-control study","volume":"148","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0015","first-page":"137","article-title":"Dyslipidemia in skin disease: Now we know more and should do more","volume":"11","author":"Kroumpouzos","year":"2013","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0020","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/en.2012-1366","article-title":"Animal models and the developmental origins of polycystic ovary syndrome: Increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction","volume":"153","author":"Franks","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0025","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1743-6109.2009.01467.x","article-title":"Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome","volume":"6","author":"Filippi","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0030","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/jsm.12695","article-title":"Estrogen mediates metabolic syndrome-induced erectile dysfunction: A study in the rabbit","volume":"11","author":"Vignozzi","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2015.09.003","article-title":"Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function","volume":"154","author":"Wang","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.repbio.2013.09.007","article-title":"Mouse models to study polycystic ovary syndrome: A possible link between metabolism and ovarian function?","volume":"14","author":"van Houten","year":"2014","journal-title":"Reprod Biol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0045","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11886-014-0467-6","article-title":"Endogenous sex hormones, metabolic syndrome, and diabetes in men and women","volume":"16","author":"Kim","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ije\/dyq158","article-title":"Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"40","author":"Brand","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0060","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2164\/jandrol.108.007245","article-title":"The dark side of testosterone deficiency: III. Cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: A meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0075","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: A population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0085","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2006-2764","article-title":"Aging, androgens and metabolic syndrome in a longitudinal study on aging","volume":"92","author":"Rodriguez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2004.12.011","article-title":"Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: The Fungata study","volume":"54","author":"Kameda","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e318185e249","article-title":"Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women\u2019s Health Across the Nation","volume":"16","author":"Torrens","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen\/Progestin Replacement Study","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0105","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2004-1479","article-title":"The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: A randomized, double-blind, placebo-controlled trial","volume":"90","author":"Sites","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2011.04189.x","article-title":"Acute testosterone deprivation reduces insulin sensitivity in men","volume":"76","author":"Rubinow","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0115","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","article-title":"Effects of androgenic-anabolic steroids in athletes","volume":"34","author":"Hartgens","year":"2004","journal-title":"Sports Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000319635","article-title":"Androgen replacement therapy in late-onset hypogonadism: Current concepts and controversies \u2013 a mini-review","volume":"57","author":"M\u00e4kinen","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2010.04.056","article-title":"Metabolic impact of sex hormones on obesity","volume":"1350","author":"Brown","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0135","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1210\/jc.2012-1614","article-title":"Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women\u2019s Health Across the Nation","volume":"97","author":"Wildman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0145","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/2047487312452965","article-title":"The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome","volume":"20","author":"Haring","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/pch\/10.1.41","article-title":"The metabolic syndrome in children and adolescents","volume":"10","author":"Hadjiyannakis","year":"2005","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0155","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1067\/mpd.2001.118535","article-title":"Insulin resistance syndrome in childhood: Associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors","volume":"139","author":"Sinaiko","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00005082-200607000-00014","article-title":"Changing our future: Obesity and the metabolic syndrome in children and adolescents","volume":"21","author":"Harrell","year":"2006","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00431-015-2604-7","article-title":"Early menarche is associated with metabolic syndrome and insulin resistance in premenopausal Korean women","volume":"175","author":"Lim","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpeds.2015.04.032","article-title":"Age at menarche and cardiometabolic risk in adulthood: The Coronary Artery Risk Development in Young Adults Study","volume":"167","author":"Dreyfus","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0175","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/EJE-15-0275","article-title":"Mechanisms in endocrinology: Metabolic syndrome through the female life cycle","volume":"173","author":"Vryonidou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-7075-9-99","article-title":"Association of age at menarche with metabolic syndrome and its components in rural Bangladeshi women","volume":"9","author":"Akter","year":"2012","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/EDE.0b013e3181567faf","article-title":"Age of menarche and the metabolic syndrome in China","volume":"18","author":"Heys","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jcem-72-2-277","article-title":"Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism","volume":"72","author":"Amiel","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0195","doi-asserted-by":"crossref","first-page":"177.e1","DOI":"10.1016\/j.ajog.2009.03.031","article-title":"Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: The CARDIA study","volume":"201","author":"Gunderson","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2007.06.011","article-title":"Metabolic syndrome in normal and complicated pregnancies","volume":"137","author":"Bartha","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00001703-200312000-00002","article-title":"Pregnancy: A stress test for life","volume":"15","author":"Williams","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2009.07.003","article-title":"The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus","volume":"35","author":"Chatzi","year":"2009","journal-title":"Diabete Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0215","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/met.2013.0153","article-title":"Prepregnancy body mass index and prenatal fasting glucose are effective predictors of early postpartum metabolic syndrome in Spanish mothers with gestational diabetes","volume":"12","author":"Barquiel","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1210\/jc.2009-1990","article-title":"Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women","volume":"95","author":"Retnakaran","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9378(95)90582-0","article-title":"Gestational diabetes diagnostic criteria: Long-term maternal follow-up","volume":"172","author":"Kaufmann","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/bmj.326.7394.845","article-title":"Hypertensive disorder of pregnancy and risk of hypertension and stroke in later life","volume":"326","author":"Wilson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1586\/14779072.5.2.283","article-title":"Preeclampsia and future cardiovascular risk","volume":"5","author":"Newstead","year":"2007","journal-title":"Expert Rev Cardiovas Ther"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0240","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/01.AOG.0000163252.02227.f8","article-title":"Early occurrence of metabolic syndrome after hypertension in pregnancy","volume":"105","author":"Forest","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0245","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1161\/CIRCOUTCOMES.115.002464","article-title":"Parity and components of the metabolic syndrome among US Hispanic\/Latina women: results from the Hispanic community health study\/study of Latinos","volume":"9","author":"Vladutiu","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0250","first-page":"63","article-title":"Menopause and metabolic syndrome: A study of 498 urban women from western India","volume":"1","author":"Pandey","year":"2010","journal-title":"J Midlife Health"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0255","first-page":"158","article-title":"Menopause and the metabolic syndrome","volume":"5","author":"Joylene","year":"2015","journal-title":"Panacea J Med Sci"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0260","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaad.2015.05.026","article-title":"Evidence-based approach to cutaneous hyperandrogenism in women","volume":"73","author":"Schmidt","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0265","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1016\/S0002-9343(99)80072-2","article-title":"Effects of sex steroids on women\u2019s health: Implications for practitioners","volume":"98","author":"Derman","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0275","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/2229-5178.202275","article-title":"Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study","volume":"8","author":"Keen","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00016340903353284","article-title":"Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism","volume":"89","author":"Ozdemir","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: Experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0290","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/tog.12030","article-title":"Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism","volume":"15","author":"Meek","year":"2013","journal-title":"Obstet Gynaecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-55-2-251","article-title":"Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women","volume":"55","author":"Glickman","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0310","first-page":"373","article-title":"Hirsutism in women","volume":"85","author":"Bode","year":"2012","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0315","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: An update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0320","first-page":"1099","article-title":"Androgen-secreting adrenal adenomas","volume":"100","author":"Danilowics","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962011000100015","article-title":"Polycystic ovary syndrome: A dermatologic approach","volume":"86","author":"Moura","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.beem.2006.02.005","article-title":"Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome","volume":"20","author":"Goodarzi","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0335","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0340","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","article-title":"The role of low-grade inflammation in the polycystic ovary syndrome","volume":"335","author":"Repaci","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0350","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00128071-200708040-00003","article-title":"Dermatologic manifestations of polycystic ovary syndrome","volume":"8","author":"Lee","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0355","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2265.2007.03145.x","article-title":"The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome","volume":"69","author":"Amato","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0360","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1530\/EJE-10-0205","article-title":"Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome","volume":"162","author":"Alemzadeh","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0365","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014Part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0370","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.1.02058","article-title":"Metabolic syndrome in polycystic ovary syndrome (PCOS): Lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS","volume":"154","author":"Carmina","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0375","first-page":"490","article-title":"Metabolic syndrome in patients with polycystic ovary syndrome in Iran","volume":"9","author":"Zahiri","year":"2016","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0380","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0385","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0390","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0395","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF03345554","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"29","author":"Essah","year":"2006","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0400","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpeds.2012.11.019","article-title":"Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents","volume":"162","author":"Roe","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0405","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: A comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: Diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin Med Res"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0415","first-page":"232","article-title":"Polycystic ovary syndrome: A major unrecognized cardiovascular risk factor in women","volume":"2","author":"Alexander","year":"2009","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40618-014-0215-1","article-title":"Cardiovascular risk factors and events in women with androgen excess","volume":"38","author":"Macut","year":"2015","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0425","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0430","first-page":"322","article-title":"Association of insulin resistance with hyperandrogenia in women","volume":"54","author":"Pugeat","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0435","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0440","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: Polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"885","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0445","first-page":"CD005552","article-title":"Insulin-sensitizing drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"1","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0450","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: A Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0455","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/1806-9282.61.03.215","article-title":"Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome","volume":"61","author":"Iwata","year":"2015","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0460","first-page":"30","article-title":"Metabolic syndrome: Polycystic ovary syndrome","volume":"435","author":"Mortada","year":"2015","journal-title":"FP Essent"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0465","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0470","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/13625187.2010.502583","article-title":"Hormonal contraception in women with the metabolic syndrome: A narrative review","volume":"15","author":"Verhaeghe","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0475","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/met.2013.0145","article-title":"Relation of acanthosis nigricans to metabolic syndrome in overweight and obese women","volume":"12","author":"Ayaz","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0480","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/diacare.25.6.1009","article-title":"Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: The Cherokee Diabetes Study","volume":"25","author":"Stoddart","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0485","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/jpem-2012-0117","article-title":"Acanthosis nigricans predicts the clustering of metabolic syndrome components in Hispanic elementary school-aged children","volume":"25","author":"Kong","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0490","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/1346-8138.12052","article-title":"Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index","volume":"40","author":"Dong","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1059840511430952","article-title":"Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review","volume":"28","author":"Abraham","year":"2012","journal-title":"J Sch Nurs"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0500","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0019-5154.113950","article-title":"Metabolic syndrome and skin: Psoriasis and beyond","volume":"58","author":"Padhi","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0505","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/11537000-000000000-00000","article-title":"Acne keloidalis nuchae: Another cutaneous symptom of metabolic syndrome, truncal obesity, and impending\/overt diabetes mellitus?","volume":"11","author":"Verma","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0510","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2340\/00015555-1677","article-title":"Acne: Risk indicator for increased body mass index and insulin resistance","volume":"93","author":"Melnik","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0515","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5114\/pdia.2015.53047","article-title":"Insulin resistance in severe acne vulgaris","volume":"32","author":"Emiro\u011flu","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0520","first-page":"353","article-title":"Association between isolated female acne and insulin resistance: A prospective study","volume":"151","author":"Kartal","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0525","first-page":"449","article-title":"Study of lipid profile in adult women with acne","volume":"8","author":"da Cunha","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0530","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12020-012-9647-6","article-title":"Insulin resistance and acne: A new risk factor for men?","volume":"42","author":"Del Prete","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0535","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamadermatol.2015.4499","article-title":"Insulin resistance and metabolic syndrome in young men with acne","volume":"152","author":"Nagpal","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0540","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/2141-9248.129040","article-title":"Acrochordons as a cutaneous sign of metabolic syndrome: A case-control study","volume":"4","author":"Shah","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0545","first-page":"25","article-title":"Association between skin tags and insulin resistance","volume":"85","author":"Tamega Ade","year":"2010","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0550","first-page":"BC09","article-title":"Assessment of various biochemical parameters and BMI in patients with skin tags","volume":"10","author":"Wali","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0555","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabet.2015.11.004","article-title":"Association between multiple skin tags and metabolic syndrome: A multicentre cross-sectional study in primary care","volume":"42","author":"Hui","year":"2016","journal-title":"Diabete Metab"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0560","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-009-0086-5","article-title":"The metabolic profile in patients with skin tags","volume":"10","author":"Sari","year":"2010","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0565","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: A comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0570","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0575","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0580","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0585","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0590","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: A little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0595","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0600","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0605","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0610","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0615","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5021\/ad.2016.28.2.147","article-title":"Management of hidradenitis suppurativa in patients with metabolic comorbidities","volume":"28","author":"Lim","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0620","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0974-7753.171566","article-title":"Is early onset androgenic alopecia a marker of metabolic syndrome and carotid artery atherosclerosis in young Indian male patients?","volume":"7","author":"Banger","year":"2015","journal-title":"Int J Trichology"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0625","first-page":"947","article-title":"Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: A case-control study","volume":"96","author":"Pengsalae","year":"2013","journal-title":"J Med Assoc Thail"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0630","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","article-title":"A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women","volume":"152","author":"Sanke","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0635","first-page":"597","article-title":"Association between androgenetic alopecia and metabolic syndrome: A meta-analysis","volume":"43","author":"Wu","year":"2014","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0640","doi-asserted-by":"crossref","first-page":"980310","DOI":"10.1155\/2015\/980310","article-title":"Is there really relationship between androgenetic alopecia and metabolic syndrome?","volume":"2015","author":"Ozbas Gok","year":"2015","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0645","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2133.2012.10978.x","article-title":"Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population","volume":"167","author":"Yi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0650","first-page":"220","article-title":"Association of androgenetic alopecia and hypertension","volume":"17","author":"Ahouansou","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0655","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.2009.09588.x","article-title":"Hypertension and aldosterone levels in women with early-onset androgenetic alopecia","volume":"162","author":"Arias-Santiago","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0660","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(00)02763-X","article-title":"Early androgenetic alopecia as a marker of insulin resistance","volume":"356","author":"Matilainen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0665","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-4632.2010.04677.x","article-title":"Androgenetic alopecia and insulin resistance: Are they truly associated?","volume":"50","author":"Abdel Fattah","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0670","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2010.05.002","article-title":"Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia","volume":"65","author":"Arias-Santiago","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0675","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2340\/00015555-0926","article-title":"A comparative study of dyslipidaemia in men and woman with androgenic alopecia","volume":"90","author":"Arias-Santiago","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0680","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08037051.2015.1111021","article-title":"Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk","volume":"25","author":"Ertas","year":"2016","journal-title":"Blood Press"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0685","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2009.10.018","article-title":"Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study","volume":"63","author":"Arias-Santiago","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0690","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/ijd.13303","article-title":"Association of metabolic syndrome with female pattern hair loss in women: A case-control study","volume":"55","author":"El Sayed","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7525-3-49","article-title":"Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population-based study","volume":"3","author":"Hirsso","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0700","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D38525G87B","article-title":"Androgenetic alopecia and coronary artery disease in women","volume":"11","author":"Mansouri","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0705","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.hjr.0000070200.72977.c6","article-title":"Hair loss, insulin resistance, and hereditary in middle-aged women. A population-based study","volume":"10","author":"Matilainen","year":"2003","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0710","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0715","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-2133.2009.09078.x","article-title":"Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?","volume":"160","author":"Abdel Fattah","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0720","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2230.2008.03118.x","article-title":"Androgenetic alopecia and insulin resistance: Are they really related?","volume":"34","author":"Nabaie","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0725","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1111\/ijd.12783","article-title":"Atherogenic index of plasma in non-obese women with androgenetic alopecia","volume":"54","author":"Bakry","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.EWX.0000407128.10834.1e","article-title":"Female pattern hair loss: The relation to metabolic syndrome in premenopausal women","volume":"9","author":"Zaki","year":"2012","journal-title":"J Egypt Women Dermatol Soc"},{"key":"10.1016\/j.clindermatol.2017.09.013_bb0735","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1210\/jc.2003-031626","article-title":"The investigation of insulin resistance in patients with idiopathic hirsutism","volume":"89","author":"Unl\u00fchizarci","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T15:43:03Z","timestamp":1692978183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X17301712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0738081X17301712"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gynecologic and andrologic dermatology and the metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}